Colonial Trust Advisors Anavex Life Sciences Corp. Transaction History
Colonial Trust Advisors
- $1.14 Billion
- Q3 2024
A detailed history of Colonial Trust Advisors transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Colonial Trust Advisors holds 200 shares of AVXL stock, worth $1,726. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 200
-0.0%
Holding current value
$1,726
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding AVXL
# of Institutions
155Shares Held
27.3MCall Options Held
515KPut Options Held
838K-
Black Rock Inc. New York, NY6.39MShares$55.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.74MShares$40.9 Million0.0% of portfolio
-
State Street Corp Boston, MA3.07MShares$26.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.88MShares$16.3 Million0.0% of portfolio
-
Wealthgarden F.S. LLC El Segundo, CA910KShares$7.86 Million0.32% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $673M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...